文献速递其他结缔组织病

新型EULAR/ACR特发性炎症性肌病分类标准在大型单中心队列中的性能评估

Performance of the new EULAR/ACR classification criteria for idiopathic inflammatory myopathies (IIM) in a large monocentric IIM cohort.
PubMed 文献 · Semin Arthritis Rheum · 2019-12-28

本研究在瑞典Karolinska大学医院439例连续特发性炎症性肌病(IIM)患者中评估2017年EULAR/ACR分类标准的性能,并与Bohan和Peter(BP)标准及医生诊断比较。结果显示EULAR/ACR标准敏感性为87.7%,高于BP标准的80.4%,两者一致性低(k=0.253,p<0.001);EULAR/ACR标准对多发性肌炎、皮肌炎和包涵体肌炎亚组特异性均>98%,敏感性在包涵体肌炎(98%)和皮肌炎(90%)较高,多发性肌炎较低(73%)。将间质性肺病(ILD)纳入标准变量后,额外6例(1.3%)被分类为IIM。

要点

  • EULAR/ACR标准敏感性87.7%,高于BP标准的80.4%,两者一致性低(k=0.253)。
  • EULAR/ACR标准对多发性肌炎、皮肌炎和包涵体肌炎特异性均>98%。
  • 将ILD纳入标准变量后额外6例(1.3%)被分类为IIM。

核心结论

  • EULAR/ACR标准在IIM中具有高敏感性和高特异性,是较既往标准的重要进步。

研究设计与样本

  • 单中心队列研究,纳入瑞典Karolinska大学医院439例连续诊断为IIM的患者,由专家医师诊断并亚分类。

主要发现

  • EULAR/ACR标准敏感性为87.7%,BP标准为80.4%。
  • 两套标准一致性低(k=0.253,p<0.001)。
  • EULAR/ACR标准对多发性肌炎、皮肌炎和包涵体肌炎特异性均>98%。
  • 敏感性在包涵体肌炎为98%,皮肌炎为90%,多发性肌炎为73%。
  • 将ILD纳入标准变量后,额外6例(1.3%)被分类为IIM。

关键数值与推荐

  • EULAR/ACR标准敏感性87.7%,BP标准敏感性80.4%。
  • 两标准一致性k=0.253(p<0.001)。
  • EULAR/ACR标准对多发性肌炎、皮肌炎和包涵体肌炎特异性>98%。
  • 亚组敏感性:包涵体肌炎98%,皮肌炎90%,多发性肌炎73%。
  • 纳入ILD后额外分类6例(1.3%)为IIM。

临床怎么用

  • EULAR/ACR标准可利用现有数据库和临床病历数据应用,有助于提高IIM临床试验和研究质量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In 2017, the European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR) published new classification criteria for idiopathic inflammatory myopathies (IIM). OBJECTIVES: To [1] assess the performance of the EULAR/ACR criteria in a monocentric cohort of consecutive patients with IIM, compare them with the Bohan and Peter (BP) criteria, and with the physician's diagnosis; and [2] evaluate the effect of including the presence of interstitial lung disease (ILD) as variable in the criteria. METHODS: 439 consecutive patients with a diagnosis of IIM followed at the Rheumatology Clinic, Karolinska University Hospital, Sweden were enrolled. The patients were diagnosed as IIM and subclassified by expert physicians. Clinical, laboratory, serological and histopathological data were collected from existing databases (Euromyositis registry and Swedish Rheumatology quality registry) and clinical charts of the patients. The sensitivity of the EULAR/ACR and the BP criteria was calculated. RESULTS: The EULAR/ACR criteria had a higher sensitivity (87.7%) compared to the BP criteria (80.4%). The concordance between the two sets of criteria was low (k = 0.253 p<0.001). The EULAR/ACR criteria showed a very high specificity (>98%) for the major IIM subgroups polymyositis, dermatomyositis, and inclusion body myositis. The sensitivity was variable and was high in inclusion body myositis (98%), dermatomyositis (90%) and lower in polymyositis (73%). When including ILD in the variables of the criteria, six more patients were classified as IIM cases (1.3%). CONCLUSION: The EULAR/ACR criteria for IIM are applicable with high sensitivity and specificity using data available from existing databases and clinical charts and represent a major step forward from the previous criteria for IIM and its subgroups. Their application will improve the quality of clinical trials and research studies with IIM patients.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Barsotti S, Dastmalchi M, Notarnicola A, et al. Performance of the new EULAR/ACR classification criteria for idiopathic inflammatory myopathies (IIM) in a large monocentric IIM cohort. Semin Arthritis Rheum. 2019. PMID: 32024593. doi:10.1016/j.semarthrit.2019.12.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。